Polar Capital’s bluebird bio BLUE Stock Holding History

Polar Capital’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,351	Closed	-$3.12M	–	260
2017 Q4	$3.12M	Buy	+1,351	New	+$2.74M	0.03%	224
2017 Q2	–	Sell	-1,544	Closed	-$1.82M	–	243
2017 Q1	$1.82M	Buy	+1,544	New	+$1.57M	0.03%	235
2016 Q4	–	Sell	-11,787	Closed	-$10.3M	–	257
2016 Q3	$10.3M	Buy	+11,787	New	+$8.54M	0.18%	142

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Polar Capital's BLUE Position: Q1 2018 in Review

Polar Capital sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 1,351 shares — an estimated $3.12M sold.

Polar Capital first reported a position in BLUE in Q3 2016 and held it in 3 quarters. The position peaked at $10.3M in Q3 2016. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

Polar Capital reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
Polar Capital sold 1,351 bluebird bio shares in Q1 2018, an estimated $3.12M.
Polar Capital first reported a position in bluebird bio in Q3 2016 and held it in 3 quarters.
Polar Capital's bluebird bio position peaked at $10.3M in Q3 2016.
303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on Polar Capital's 13F filing for Q1 2018, filed 15 May 2018.